Immunohistochemical study on liver fibrosis in biliary atresia

Hepato-Gastroenterology

Volumn 55, Issue 81, 2008, Pages 179-183

  Murata, Kiyoshi ^a   Kamata, Yoshimasa ^b   Munakata, Hirohumi ^c   Sugai, Michihiro ^c   Sasaki, Mutsuo ^c  

^a NATIONAL HOSPITAL ORGANIZATION DISASTER MEDICAL CENTER   (Japan)

^b HIROSAKI UNIVERSITY HOSPITAL   (Japan)

^c HIROSAKI UNIVERSITY   (Japan)

Author keywords

Biliary atresia; Immunohistochemistry; Liver fibrosis; MMP; TIMP

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GELATINASE A; INTERSTITIAL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR;

ANALYTIC METHOD; ARTICLE; BILE DUCT ATRESIA; CELL STRUCTURE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFANT; LIVER; LIVER FIBROSIS; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ACTINS; BILIARY ATRESIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LIVER CIRRHOSIS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; PLATELET-DERIVED GROWTH FACTOR; PORTOENTEROSTOMY, HEPATIC; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TRANSFORMING GROWTH FACTOR BETA;

EID: 41549114550     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ohi R, Nio M: The jaundiced infant: biliary atresia and other obstructions. In: O'Neill Jr. JA, Eowe MI, Grosfeld JL, Frankalsrud EW, Coran AG (Eds.). Pediatric Surgery. 5th Edition. Missouri: Mosby, 1998; pp. 1465-1481.
2. Kasai M, Suzuki S: A new operation for "non-correctable" biliary atresia: hepatic portoenterostomy. Shujyutu 1959; 13:733-739. (In Japanese)
3. Balistreri WF, Grand R, Hoofnagle JH, Suchy FJ, Ryckman DH, Sokol RJ: Biliary atresia: current concepts and research directions.Summary of symposium. Hepatology 1996; 23:1682-1692.
4. Carceller A, Blanchard H, Alvarez F, St-Vil D, Bensoussan AL, Lorenzo MD: Past and future of biliary atresia. J Pediatr Surg 2000; 35:717-720.
5. Ramm GA, Nair VG, Bridle KR, Shepherd RW, Crawford DHG: Contribution of hepatic parenchymal and non-parenchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol 1998; 153:527-535.
6. Friedman SL: The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993;328:1828-1835.
7. Nagase H, Woessner JF: Matrix metalloproteinases. J Biol Chem 1999; 274:21491-21494.
8. Suruga K, Miyano T, Kitahara T, Kojima Y, Fukuda Y: Treatment of biliary atresia: a study of our operative results. J Ped Surg 1981; 16:621-626.
9. Lee KS, Buck M, Houglum K, Chojkier M: Activation of hepatic stellate cells by TGF-β and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995; 96:2461-2468.
10. Marra F, Choudhury GG, Pinzani M, Abboud HE: Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. Gastroenterology 1994; 107:1110-1117.
11. Casini A, Pinzani M, Milani S, Grappone C, Galli G, Jezequel AM, Schuppan D, Rotella CM: Regulation of extracellular matrix synthesis by transforming growth factor β 1 in human fat-storing cells. Gastroenterology 1993; 105:245-253.
12. Pinzani M, Gesukado L, Sabbah GM, Abboud HE: Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat storing cells. J Clin Invest 1989; 84:1786-1793.
13. Pinzani M, Milani S, Herbst H, DeFranco R, Grappone C, Gentilini A, Caligiuri A, Pellegrini G, Ngo DV, Romanelli RG, Gentilini P: Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol 1996; 148:785-800.
14. Malizia G, Brunt EM, Peters MG, Rizzo A, Broekelmann TJ, McDonald JA: Growth factor and procollagen I gene expression in human liver disease. Gastroenterology 1995; 108:145-156.
15. Ahmed AFKU, Ohtani H, Nio M, Funaki N, Iwami D, Kumagai S, Sato E, Nagura H, Ohi R: In situ expression of fibrogenic growth factors and their receptors in biliary atresia:comparison between early and late stages. J Pathol 2000; 192:73-80.
16. Border WA, Noble NA: Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331:1286-1292.
17. Friedman SL: Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275:2247-2250.
18. Arthur MJP: Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. Am J Physiol Gastrointest Liver Physiol 2000; 279:G245-G249.
19. Carter EA, McCarron MJ, Alpert E, Isselbacher KJ: Lysyl oxidase and collagenase in experimental acute and chronic liver injury. Gastroenterology 1982; 82:526-534.
20. Montfort I, Perez-Tamayo R, Alvizouri AM, Tello E: Collagenase of hepatocytes and sinusoidal liver cells in the reversibility of experimental cirrhosis of the liver. Virchows Archiv B Cell Pathol 1990; 59:281-289.
21. Takahara T, Furui K, Funaki J, Nakayama Y, Itoh H, Miyabayashi C, Sato H, Seiki M, Ooshima A, Watanabe A: Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats. Hepatology 1995; 21:787-795.
22. Nagase H: Storomelysins 1 and 2. In: Parks WC, Mecham RP (Eds.). Matrix metalloproteinases. San Diego: Academic Press, 1998; pp. 43-84.
23. Benyon RC, Iredare JP, Goddard S, Winwood PJ, Arthur MJ: Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver. Gastroenterology 1996; 110:821-831.
24. Iredale JP, Goddard S, Murphy G, Benyon RC, Arthur MJP: Tissue inhibitor of metalloproteinase-I and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes. Clin Sci 1995; 89:75-81.
25. Okazaki I, Watanabe T, Hozawa S, Niioka M, Arai M, Maruyama K: Reversibility of hepatic fibrosis: from the first report of collagenase in liver to the possibility of gene therapy for recovery. Keio J Med 2001; 50:58-65.